TMC Life Sciences Berhad Sustainability Profile
TMC Life Sciences Berhad, a prominent player in the biotechnology and healthcare sector, is headquartered in Malaysia. Founded in 1994, the company has established itself as a leader in providing innovative healthcare solutions, particularly in the fields of regenerative medicine and clinical research. With a strong operational presence across Southeast Asia, TMC Life Sciences focuses on advanced medical technologies and services that enhance patient care. The company offers a range of core products and services, including stem cell therapies and clinical trial management, distinguished by their commitment to quality and scientific excellence. TMC Life Sciences has achieved significant milestones, positioning itself as a trusted name in the industry, recognised for its contributions to medical advancements and patient outcomes.
DitchCarbon Score
How does TMC Life Sciences Berhad's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
TMC Life Sciences Berhad's score of 19 is lower than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
TMC Life Sciences Berhad's reported carbon emissions
In 2023, TMC Life Sciences Berhad reported total carbon emissions of approximately 36,081,000 kg CO2e from Scope 2, 600,410 kg CO2e from Scope 1, and 1,814,000 kg CO2e from Scope 3, specifically related to business travel. This data reflects a comprehensive approach to emissions reporting, with disclosures across all three scopes. Comparatively, in 2022, the company recorded 31,190,000 kg CO2e in Scope 2 and 316,050 kg CO2e in Scope 1, indicating a significant increase in emissions in 2023. The Scope 1 and 2 emissions for 2021 were 14,390,000 kg CO2e and 263,150 kg CO2e, respectively, showcasing a trend of rising emissions over the years. TMC Life Sciences Berhad does not currently have specific reduction targets or initiatives disclosed, nor does it participate in the Science Based Targets initiative (SBTi). The emissions data is cascaded from its parent company, Thomson Medical Group Limited, reflecting the broader corporate commitment to sustainability. The company’s carbon intensity metrics include approximately 210,000 MtCO2e per square metre of gross floor area and 60 MtCO2e per MYR 1,000 in revenue, indicating a focus on operational efficiency in relation to emissions. Overall, TMC Life Sciences Berhad is positioned within a growing industry context that increasingly prioritises climate commitments, although specific reduction strategies remain unspecified at this time.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 263,150 | 000,000 | 000,000 |
| Scope 2 | 14,390,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | 0,000,000 |
How Carbon Intensive is TMC Life Sciences Berhad's Industry?
How Carbon Intensive is TMC Life Sciences Berhad's Location?
TMC Life Sciences Berhad's Scope 3 Categories Breakdown
Their carbon footprint includes suppliers and value chain emissions, with Scope 3 emissions accounting for 5% of total emissions under the GHG Protocol, with "Business Travel" representing nearly all of their reported Scope 3 footprint.
Top Scope 3 Categories
TMC Life Sciences Berhad's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
TMC Life Sciences Berhad has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
